Melancholic features (DSM-IV) predict but do not moderate response to antidepressants in major depression: an individual participant data meta-analysis of 1219 patients-Reference-Cited by-同舟云学术

Melancholic features (DSM-IV) predict but do not moderate response to antidepressants in major depression: an individual participant data meta-analysis of 1219 patients

Published:2020-07-26 Issue:3 Volume:271 Page:521-526
ISSN:0940-1334
Container-title:European Archives of Psychiatry and Clinical Neuroscience
language:en
Short-container-title:Eur Arch Psychiatry Clin Neurosci

Author:

Imai Hissei^ORCID,Noma Hisashi,Furukawa Toshi A.

Funder

Japan Agency for Medical Research and Development

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00406-020-01173-4.pdf

Reference35 articles.

1. American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders, 3rd edn. American Psychiatric Publishing, Washington, DC

2. American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Association, Arlington

3. Sadock B, Sadock V, Ruiz P (2015) Synopsis of psychiatry, 11th edn. Lippincott Williams & Wilkins, Philadelphia

4. Kendell RE (1993) Mood (affective) disorder. In: Kendell RE, Zealley AK (eds) Companion to psychiatric studies, 5th edn. Churchill Licingstone, New York, pp 427–457

5. Prusoff BA, Weissman MM, Klerman GL, Rounsaville BJ (1980) Research diagnostic criteria subtypes of depression. Their role as predictors of differential response to psychotherapy and drug treatment. Arch Gen Psychiatry 37:796–801

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Features of immunometabolic depression as predictors of antidepressant treatment outcomes: pooled analysis of four clinical trials;The British Journal of Psychiatry;2023-12-22

2. Methods for quantifying the heterogeneity of psychopathology;BMC Psychiatry;2023-11-30

3. Apathy in melancholic depression and abnormal neural activity within the reward-related circuit;Behavioural Brain Research;2023-04

4. Metabolomic and inflammatory signatures of symptom dimensions in major depression;Brain, Behavior, and Immunity;2022-05

5. The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries;European Archives of Psychiatry and Clinical Neuroscience;2022-01-06